▁Chron 9.2890625
ic 0.54833984375
▁infl 4.5234375
amm 0.36376953125
ation 0.0083465576171875
▁in 2.818359375
▁end 6.3359375
- 2.888671875
stage 0.01390838623046875
▁ren 0.44482421875
al 0.0002579689025878906
▁disease 0.07025146484375
▁( 2.818359375
ES 0.055816650390625
R 0.0029621124267578125
D 0.0003025531768798828
) 0.1416015625
▁and 4.2890625
▁the 2.091796875
▁role 2.20703125
▁of 0.025482177734375
▁d 3.57421875
ial 0.09942626953125
ysis 0.056884765625
▁are 4.59375
▁two 4.5234375
▁critical 4.66796875
▁aspects 2.466796875
▁discussed 7.8359375
▁in 0.3662109375
▁the 1.6064453125
▁article 2.826171875
▁" 2.857421875
Chr 1.3564453125
onic 0.0006837844848632812
▁In 0.63037109375
fl 0.012481689453125
amm 0.033905029296875
ation 0.0007152557373046875
▁in 0.479248046875
▁End 0.315185546875
- 0.056488037109375
Stage 0.16357421875
▁Ren 0.01541900634765625
al 6.079673767089844e-05
▁D 0.0081939697265625
ise 0.00038433074951171875
ase 0.0012159347534179688
▁and 2.23828125
▁D 2.5859375
ial 0.0022907257080078125
ysis 0.0072021484375
". 2.712890625
▁This 2.900390625
▁ess 7.265625
ay 0.0027751922607421875
▁will 1.7802734375
▁del 5.6953125
ve 0.054779052734375
▁into 0.24462890625
▁the 0.408203125
▁leading 7.66796875
▁causes 0.4970703125
▁of 0.17333984375
▁chron 0.73876953125
ic 0.0004699230194091797
▁infl 0.033203125
amm 0.016448974609375
ation 0.0008754730224609375
▁in 0.2288818359375
▁individuals 5.4296875
▁with 0.302490234375
▁E 0.073486328125
SR 0.0010843276977539062
D 0.00014865398406982422
, 0.87353515625
▁the 0.779296875
▁impact 1.91015625
▁of 0.272216796875
▁the 5.1484375
▁disease 1.087890625
▁on 0.11553955078125
▁clin 6.890625
ical 0.0106048583984375
▁out 0.313232421875
comes 0.0007090568542480469
, 0.22216796875
▁the 2.318359375
▁role 1.0947265625
▁of 0.054473876953125
▁middle 14.734375
▁mole 0.404052734375
cules 0.29833984375
▁in 0.5166015625
▁its 5.22265625
▁development 1.6240234375
, 0.1378173828125
▁and 0.2216796875
▁the 0.36083984375
▁latest 3.83984375
▁break 4.3203125
through 0.0009441375732421875
s 0.035919189453125
▁and 3.4140625
▁research 2.685546875
▁in 0.94384765625
▁d 3.5625
ial 0.0006575584411621094
ysis 0.01007843017578125
▁to 3.11328125
▁stabil 9.234375
ize 0.043792724609375
▁the 1.5185546875
▁condition 1.2900390625
. 0.20166015625
<0x0A> 0.451171875
The 2.072265625
▁article 2.232421875
▁highlight 2.689453125
s 0.01406097412109375
▁that 1.2197265625
▁the 2.0625
▁leading 1.75390625
▁causes 0.74951171875
▁of 0.007305145263671875
▁chron 0.1103515625
ic 0.00012552738189697266
▁infl 0.005619049072265625
amm 0.0098876953125
ation 0.00012433528900146484
▁in 0.03936767578125
▁patients 2.650390625
▁with 0.0246734619140625
▁E 0.0750732421875
SR 0.0006194114685058594
D 0.00011110305786132812
▁include 1.01171875
▁ox 3.962890625
id 0.01221466064453125
ative 0.01000213623046875
▁stress 0.028778076171875
, 0.14794921875
▁mal 2.87890625
nut 0.0164947509765625
r 0.00029397010803222656
ition 0.0004820823669433594
, 0.03570556640625
▁in 3.31640625
fection 0.77294921875
, 0.04449462890625
▁and 0.4873046875
▁the 3.259765625
▁accum 2.73828125
ulation 0.0039215087890625
▁of 0.0025615692138671875
▁middle 1.75
▁mole 0.027862548828125
cules 0.009674072265625
. 0.7939453125
▁These 1.8515625
▁factors 0.74755859375
▁contribute 1.365234375
▁to 0.056915283203125
▁the 0.43701171875
▁activation 4.21875
▁of 0.03900146484375
▁pro 1.7685546875
- 0.2880859375
infl 0.005779266357421875
am 0.00052642822265625
mat 4.673004150390625e-05
ory 8.940696716308594e-06
▁path 0.740234375
ways 0.0013141632080078125
▁in 2.4609375
▁the 0.10540771484375
▁body 0.140625
, 0.1756591796875
▁leading 0.497802734375
▁to 0.0001354217529296875
▁sust 7.74609375
ained 0.002323150634765625
▁infl 0.160888671875
amm 0.11322021484375
ation 0.00011670589447021484
. 1.4384765625
▁The 1.193359375
▁presence 4.76953125
▁of 0.00286865234375
▁chron 1.4267578125
ic 0.00041937828063964844
▁infl 0.007389068603515625
amm 0.004608154296875
ation 4.792213439941406e-05
▁further 5.9921875
▁ex 1.4072265625
ac 0.007450103759765625
erb 4.482269287109375e-05
ates 0.0015277862548828125
▁the 0.36962890625
▁pro 2.470703125
gression 0.0557861328125
▁of 0.011962890625
▁ren 3.4375
al 1.9550323486328125e-05
▁failure 1.7861328125
, 0.7734375
▁creating 6.52734375
▁a 0.09088134765625
▁v 0.10467529296875
icious 5.519390106201172e-05
▁cycle 0.006038665771484375
. 1.80859375
▁By 7.35546875
▁understanding 1.162109375
▁these 3.244140625
▁leading 2.412109375
▁causes 0.0298614501953125
, 0.64453125
▁health 0.85888671875
care 0.0478515625
▁profession 0.564453125
als 2.0265579223632812e-06
▁can 0.09161376953125
▁dev 4.07421875
ise 0.0007700920104980469
▁inter 3.814453125
vent 0.026214599609375
ions 0.00960540771484375
▁to 0.26708984375
▁mit 1.8701171875
ig 1.9073486328125e-06
ate 4.076957702636719e-05
▁infl 2.09765625
amm 0.071044921875
ation 9.202957153320312e-05
▁and 0.336181640625
▁potentially 4.92578125
▁improve 0.6044921875
▁clin 0.9619140625
ical 0.0003571510314941406
▁out 0.0012674331665039062
comes 1.3947486877441406e-05
▁for 1.4306640625
▁patients 0.442626953125
▁with 0.157958984375
▁E 0.0204315185546875
SR 0.00012171268463134766
D 1.0251998901367188e-05
. 0.035736083984375
<0x0A> 0.06622314453125
ES 5.63671875
R 0.002803802490234375
D 0.0003752708435058594
▁has 3.6484375
▁a 1.0791015625
▁significant 0.74267578125
▁impact 0.0716552734375
▁on 0.001987457275390625
▁clin 0.356201171875
ical 0.00020444393157958984
▁out 0.0029621124267578125
comes 4.1961669921875e-05
, 0.38427734375
▁resulting 4.48828125
▁in 0.00878143310546875
▁increased 1.26171875
▁mor 1.064453125
bid 0.00032806396484375
ity 0.0016145706176757812
▁and 0.11102294921875
▁mort 0.0146484375
ality 3.147125244140625e-05
▁rates 1.18359375
. 0.2578125
▁The 0.7880859375
▁chron 3.65234375
ic 0.017120361328125
▁infl 0.111328125
amm 0.229248046875
ation 5.793571472167969e-05
▁associated 0.89599609375
▁with 0.00020062923431396484
▁E 1.236328125
SR 0.00013566017150878906
D 2.2530555725097656e-05
▁cont 1.923828125
ributes 2.9802322387695312e-06
▁to 0.06591796875
▁card 4.25390625
i 0.00551605224609375
ov 0.0010118484497070312
asc 2.014636993408203e-05
ular 0.00010955333709716797
▁comp 3.197265625
lications 0.000553131103515625
, 0.1396484375
▁an 3.12109375
emia 0.1619873046875
, 0.00431060791015625
▁b 2.03125
one 0.00844573974609375
▁disease 0.469970703125
, 0.005474090576171875
▁and 0.2939453125
▁imm 4.01171875
un 1.6572265625
ode 1.5439453125
fic 0.0029087066650390625
iency 0.0271148681640625
, 0.86376953125
▁among 0.9951171875
▁other 0.19873046875
▁comp 2.42578125
lications 0.00022780895233154297
. 0.06494140625
▁The 1.72265625
▁continuous 6.328125
▁activation 2.3828125
▁of 0.009307861328125
▁pro 0.472412109375
- 0.0085296630859375
infl 0.00118255615234375
am 0.00012695789337158203
mat 2.86102294921875e-06
ory 3.0994415283203125e-06
▁path 0.036651611328125
ways 0.0002925395965576172
▁places 6.53125
▁additional 3.599609375
▁stress 0.50537109375
▁on 0.0012264251708984375
▁the 0.10284423828125
▁patients 6.74609375
' 0.333740234375
▁card 3.03125
i 0.040374755859375
ov 0.001056671142578125
asc 0.0001049041748046875
ular 5.447864532470703e-05
▁system 0.389892578125
, 0.201171875
▁leading 0.869140625
▁to 0.00022864341735839844
▁an 1.55859375
▁increased 0.1861572265625
▁risk 0.042633056640625
▁of 0.0200042724609375
▁heart 1.1396484375
▁disease 1.5
▁and 0.6904296875
▁stroke 0.2391357421875
. 0.044952392578125
▁Additionally 1.9404296875
, 0.0001016855239868164
▁mal 4.40234375
function 8.234375
ing 0.2056884765625
▁kid 1.509765625
ne 0.005161285400390625
ys 7.3909759521484375e-06
▁result 2.4765625
▁in 0.0010919570922851562
▁decre 3.4453125
ased 0.0026302337646484375
▁production 0.7216796875
▁of 0.00954437255859375
▁er 0.436279296875
yth 0.0007009506225585938
ro 0.0027217864990234375
po 0.0009822845458984375
iet 0.0026988983154296875
in 0.0035552978515625
, 0.11700439453125
▁leading 0.71923828125
▁to 0.0002713203430175781
▁an 0.0830078125
emia 0.0074615478515625
. 0.9775390625
▁B 2.630859375
one 0.005420684814453125
▁health 5.91796875
▁is 0.295654296875
▁also 0.45751953125
▁comprom 0.62158203125
ised 0.00010013580322265625
▁due 0.8408203125
▁to 0.00025272369384765625
▁an 4.015625
▁im 1.2294921875
bal 9.59634780883789e-05
ance 0.046478271484375
▁in 0.3828125
▁min 2.548828125
eral 0.35791015625
▁met 0.6953125
abol 2.3245811462402344e-05
ism 0.0023365020751953125
, 0.71142578125
▁resulting 1.1865234375
▁in 0.00191497802734375
▁kid 9.484375
ney 0.0005702972412109375
▁o 4.13671875
ste 0.00037097930908203125
od 0.00995635986328125
yst 0.0012712478637695312
ro 0.0024890899658203125
phy 0.00066375732421875
. 0.381103515625
▁Under 6.7109375
standing 0.1380615234375
▁the 0.141357421875
▁impact 1.095703125
▁of 0.0268096923828125
▁E 1.3359375
SR 0.00012791156768798828
D 4.0531158447265625e-06
▁on 0.2464599609375
▁clin 0.0887451171875
ical 0.00012969970703125
▁out 0.001190185546875
comes 3.2186508178710938e-06
▁emphas 5.56640625
izes 0.002307891845703125
▁the 0.003253936767578125
▁ur 3.248046875
gency 0.95458984375
▁in 4.24609375
▁developing 1.91796875
▁effective 1.1396484375
▁inter 0.454833984375
vent 0.00295257568359375
ions 0.00026726722717285156
▁to 0.1380615234375
▁manage 1.703125
▁chron 0.372314453125
ic 2.6941299438476562e-05
▁infl 0.0005125999450683594
amm 0.00366973876953125
ation 1.800060272216797e-05
. 0.50634765625
<0x0A> 0.02703857421875
Middle 1.060546875
▁mole 0.027801513671875
cules 0.0215606689453125
▁have 2.744140625
▁been 1.0029296875
▁identified 0.74560546875
▁as 0.018890380859375
▁significant 2.755859375
▁contrib 0.40380859375
utors 0.0086212158203125
▁to 0.005756378173828125
▁the 0.93359375
▁development 0.304443359375
▁of 0.07049560546875
▁path 8.7890625
ology 3.26953125
▁in 0.299072265625
▁E 0.93310546875
SR 0.00018846988677978516
D 3.0994415283203125e-05
. 0.478759765625
▁These 1.3115234375
▁mole 0.418701171875
cules 0.0020236968994140625
▁are 1.1181640625
▁intermediate 7.3359375
▁in 2.43359375
▁size 0.1314697265625
▁between 1.5595703125
▁small 0.467041015625
▁and 1.1630859375
▁large 0.0294189453125
▁sol 7.37890625
utes 0.323486328125
, 1.0732421875
▁making 1.69140625
▁them 0.1468505859375
▁difficult 1.01953125
▁to 0.1632080078125
▁be 2.83984375
▁effectively 2.314453125
▁removed 0.89697265625
▁by 0.5908203125
▁conventional 2.833984375
▁d 0.2232666015625
ial 8.344650268554688e-06
ysis 0.01303863525390625
▁methods 1.6669921875
. 0.040679931640625
▁The 1.1435546875
▁persistent 5.62109375
▁accum 1.1728515625
ulation 0.0003504753112792969
▁of 0.004367828369140625
▁middle 0.36962890625
▁mole 0.004665374755859375
cules 0.0011739730834960938
▁in 1.0986328125
▁the 0.23828125
▁body 0.2459716796875
▁triggers 3.404296875
▁an 1.9521484375
▁imm 2.46484375
une 0.08392333984375
▁response 0.0450439453125
, 0.19970703125
▁leading 0.67431640625
▁to 0.0001461505889892578
▁infl 1.7685546875
amm 0.08697509765625
ation 0.000652313232421875
. 0.9423828125
▁Furthermore 4.30859375
, 6.473064422607422e-05
▁middle 1.2568359375
▁mole 0.005825042724609375
cules 0.015716552734375
▁can 1.7197265625
▁inf 9.0078125
lict 0.1429443359375
▁ox 2.5078125
id 5.817413330078125e-05
ative 0.0016679763793945312
▁stress 0.326904296875
▁on 0.97412109375
▁cells 1.5390625
▁and 1.8173828125
▁comprom 5.765625
ise 0.00167083740234375
▁the 0.986328125
▁integrity 1.4404296875
▁of 0.0038852691650390625
▁end 4.5
oth 0.0026302337646484375
el 0.003696441650390625
ial 0.035888671875
▁function 3.244140625
, 0.5546875
▁thereby 4.3046875
▁ex 1.9501953125
ac 0.0070953369140625
erb 8.344650268554688e-07
ating 0.00014972686767578125
▁the 0.513671875
▁path 3.5703125
ology 0.77001953125
. 1.6875
▁Target 5.05078125
ing 0.26025390625
▁middle 1.1328125
▁mole 0.0025272369384765625
cules 0.052337646484375
▁and 2.7109375
▁developing 2.08984375
▁better 4.0
▁d 0.43017578125
ial 3.3974647521972656e-05
ysis 0.014404296875
▁techniques 1.26953125
▁to 0.845703125
▁eliminate 2.623046875
▁them 0.3671875
▁can 2.12890625
▁potentially 0.986328125
▁reduce 2.13671875
▁chron 2.306640625
ic 0.0001964569091796875
▁infl 0.0018587112426757812
amm 0.01071929931640625
ation 3.0159950256347656e-05
▁in 1.015625
▁patients 0.947265625
▁with 0.00856781005859375
▁E 0.00675201416015625
SR 0.00022423267364501953
D 1.3947486877441406e-05
. 0.1859130859375
<0x0A> 0.059844970703125
Rec 1.6669921875
ent 0.0227508544921875
▁break 1.0244140625
through 4.8279762268066406e-05
s 0.00341033935546875
▁and 0.876953125
▁research 0.1004638671875
▁in 0.2191162109375
▁d 0.1126708984375
ial 1.0013580322265625e-05
ysis 0.0005946159362792969
▁aim 3.00390625
▁to 0.029052734375
▁stabil 1.1650390625
ize 0.0010738372802734375
▁the 0.8447265625
▁condition 1.001953125
▁of 0.7666015625
▁individuals 1.5517578125
▁with 0.0391845703125
▁E 0.08349609375
SR 9.357929229736328e-05
D 7.748603820800781e-06
. 0.6611328125
▁The 1.630859375
▁development 1.05078125
▁of 0.00617218017578125
▁high 3.73046875
- 0.1060791015625
fl 0.162841796875
ux 0.00015032291412353516
▁d 0.462646484375
ial 2.849102020263672e-05
ysis 0.037567138671875
▁memb 1.78515625
ran 0.01023101806640625
es 4.744529724121094e-05
▁enables 4.328125
▁en 5.1796875
hanced 0.0010662078857421875
▁removal 0.65478515625
▁of 0.002323150634765625
▁middle 0.474609375
▁mole 0.01140594482421875
cules 0.0014219284057617188
, 0.474853515625
▁thereby 2.189453125
▁potentially 4.7578125
▁reducing 0.31298828125
▁chron 1.689453125
ic 4.875659942626953e-05
▁infl 0.0009212493896484375
amm 0.005329132080078125
ation 2.205371856689453e-05
. 0.1468505859375
▁Additionally 0.7666015625
, 5.1021575927734375e-05
▁the 0.81591796875
▁use 0.65576171875
▁of 0.00013768672943115234
▁con 6.66015625
ve 0.036529541015625
ct 0.2235107421875
ive 0.00015401840209960938
▁ther 2.392578125
ap 0.1513671875
ies 8.630752563476562e-05
▁like 3.185546875
▁hem 0.7060546875
odia 0.33447265625
fil 0.009429931640625
tr 0.0029926300048828125
ation 0.0003483295440673828
▁has 2.2734375
▁shown 1.7197265625
▁prom 0.361572265625
ising 2.3126602172851562e-05
▁results 0.048797607421875
▁in 0.03143310546875
▁reducing 1.0927734375
▁infl 0.72998046875
amm 0.3134765625
ation 0.00018155574798583984
▁by 3.375
▁more 4.74609375
▁effectively 0.35205078125
▁clear 3.8046875
ing 0.0006809234619140625
▁infl 6.30078125
am 0.0860595703125
mat 0.0001043081283569336
ory 4.3511390686035156e-05
▁medi 1.0439453125
ators 0.0010251998901367188
. 0.7734375
▁Research 3.66015625
ers 1.236328125
▁are 0.1737060546875
▁also 0.2142333984375
▁expl 0.442138671875
oring 9.894371032714844e-06
▁innov 4.05078125
ative 0.005519866943359375
▁approaches 1.439453125
▁such 1.1748046875
▁as 0.00021159648895263672
▁bio 4.04296875
engine 2.541015625
ered 0.701171875
▁kid 1.9228515625
ne 0.1959228515625
ys 1.2874603271484375e-05
▁and 0.67529296875
▁reg 3.10546875
ener 0.0006108283996582031
ative 0.027252197265625
▁medicine 0.18505859375
▁to 0.289794921875
▁replace 3.59765625
▁or 1.994140625
▁repair 0.423828125
▁dam 0.1495361328125
aged 0.00012433528900146484
▁kid 0.2154541015625
ne 0.019927978515625
ys 3.6954879760742188e-06
, 0.86962890625
▁offering 2.3828125
▁a 1.447265625
▁potential 0.76025390625
▁c 2.244140625
ure 4.3392181396484375e-05
▁for 0.10931396484375
▁E 0.54296875
SR 0.0001672506332397461
D 5.7220458984375e-06
. 0.1656494140625
<0x0A> 0.6455078125
In 0.70947265625
▁conclusion 0.0711669921875
, 0.0002105236053466797
▁chron 0.26513671875
ic 2.8967857360839844e-05
▁infl 0.00047135353088378906
amm 0.0006566047668457031
ation 1.4424324035644531e-05
▁in 0.1815185546875
▁E 0.6376953125
SR 0.00010323524475097656
D 2.384185791015625e-06
▁is 0.8134765625
▁a 0.061279296875
▁complex 2.552734375
▁phenomen 2.654296875
on 2.6464462280273438e-05
▁influenced 4.03125
▁by 0.0003972053527832031
▁various 1.17578125
▁factors 0.11285400390625
. 1.0615234375
▁It 3.65234375
▁significantly 3.33984375
▁impact 0.160888671875
s 2.288818359375e-05
▁clin 0.12127685546875
ical 6.413459777832031e-05
▁out 0.0005488395690917969
comes 4.0531158447265625e-06
, 0.72216796875
▁leading 2.076171875
▁to 0.00022077560424804688
▁card 3.564453125
i 0.00214385986328125
ov 0.00011396408081054688
asc 8.463859558105469e-06
ular 7.3909759521484375e-06
▁comp 0.154541015625
lications 0.00029349327087402344
, 0.0517578125
▁an 0.0755615234375
emia 0.0005445480346679688
, 0.0003807544708251953
▁b 0.06982421875
one 1.2636184692382812e-05
▁disease 0.0223236083984375
, 0.0036029815673828125
▁and 0.0254058837890625
▁imm 0.02642822265625
un 0.01511383056640625
ode 0.0005011558532714844
fic 0.00012552738189697266
iency 0.0008106231689453125
. 0.081787109375
▁Middle 1.1240234375
▁mole 0.0010776519775390625
cules 0.00937652587890625
▁play 0.619140625
▁a 0.07611083984375
▁p 3.419921875
iv 1.430511474609375e-06
otal 4.76837158203125e-07
▁role 0.00019991397857666016
▁in 0.00847625732421875
▁the 0.45947265625
▁development 0.1649169921875
▁of 0.02313232421875
▁path 1.498046875
ology 0.01079559326171875
, 0.52392578125
▁ex 4.61328125
ac 0.126220703125
erb 1.0728836059570312e-06
ating 0.11346435546875
▁chron 1.828125
ic 8.857250213623047e-05
▁infl 0.0003790855407714844
amm 0.0025653839111328125
ation 2.7060508728027344e-05
. 0.1337890625
▁However 2.833984375
, 7.128715515136719e-05
▁recent 0.560546875
▁break 0.0992431640625
through 7.748603820800781e-06
s 0.00015985965728759766
▁and 0.278564453125
▁research 0.043212890625
▁in 0.051177978515625
▁d 0.00534820556640625
ial 1.8835067749023438e-05
ysis 5.650520324707031e-05
▁hold 4.25
▁promise 0.62939453125
▁for 1.369140625
▁stabil 0.2919921875
izing 0.003383636474609375
▁the 0.0750732421875
▁condition 0.01776123046875
, 2.4765625
▁including 3.455078125
▁the 0.1934814453125
▁development 1.01171875
▁of 0.0019702911376953125
▁high 0.20654296875
- 0.0009317398071289062
fl 0.00293731689453125
ux 1.5854835510253906e-05
▁memb 1.7412109375
ran 0.007389068603515625
es 2.1338462829589844e-05
, 1.29296875
▁con 0.529296875
ve 3.719329833984375e-05
ct 0.0022754669189453125
ive 1.800060272216797e-05
▁ther 0.0201568603515625
ap 0.0039043426513671875
ies 3.0517578125e-05
, 0.0313720703125
▁and 0.15771484375
▁reg 2.517578125
ener 1.9669532775878906e-05
ative 0.0006465911865234375
▁medicine 0.018035888671875
. 0.140625
▁By 1.9111328125
▁understanding 0.77001953125
▁the 0.125244140625
▁causes 2.458984375
, 2.30078125
▁consequences 2.4140625
, 0.00606536865234375
▁and 0.0027027130126953125
▁potential 0.6953125
▁solutions 0.370361328125
, 1.1572265625
▁health 0.298095703125
care 0.00179290771484375
▁profession 0.029022216796875
als 1.1920928955078125e-06
▁can 0.039581298828125
▁improve 2.181640625
▁the 0.86328125
▁management 3.021484375
▁of 0.208251953125
▁chron 0.490966796875
ic 4.57763671875e-05
▁infl 0.0005097389221191406
amm 0.00823974609375
ation 1.6808509826660156e-05
▁in 0.125244140625
▁individuals 0.87744140625
▁with 0.00191497802734375
▁E 0.006351470947265625
SR 0.00013458728790283203
D 1.0132789611816406e-05
, 0.95947265625
▁ultimately 1.0263671875
▁impro 0.8173828125
ving 4.410743713378906e-06
▁clin 1.2314453125
ical 5.424022674560547e-05
▁out 0.0007352828979492188
comes 5.364418029785156e-06
▁and 0.53173828125
▁en 2.23046875
han 0.007122039794921875
cing 1.9073486328125e-06
▁patients 2.095703125
' 0.003292083740234375
▁quality 0.0367431640625
▁of 0.0006814002990722656
▁life 0.00019669532775878906
. 0.01031494140625
